Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?

BACKGROUND: The benefit of adjuvant chemotherapy remains controversial in muscle-invasive bladder cancer (MIBC) after radical cystectomy. The present study’s primary objective was to construct a predictive tool for the reasonable application of adjuvant chemotherapy. METHODS: All of the patients ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Junjie, Sun, Junjie, Fu, Guanghou, Xu, Zhijie, Chen, Xiaoyi, Shi, Yue, Jin, Baiye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844522/
https://www.ncbi.nlm.nih.gov/pubmed/33532324
http://dx.doi.org/10.21037/tau-20-960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844522/
https://www.ncbi.nlm.nih.gov/pubmed/33532324
http://dx.doi.org/10.21037/tau-20-960

Ejemplares similares